169 related articles for article (PubMed ID: 22851303)
1. Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells.
Ngaotepprutaram T; Kaplan BL; Crawford RB; Kaminski NE
J Neuroimmune Pharmacol; 2012 Dec; 7(4):969-80. PubMed ID: 22851303
[TBL] [Abstract][Full Text] [Related]
2. Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.
Ngaotepprutaram T; Kaplan BL; Kaminski NE
Toxicol Appl Pharmacol; 2013 Nov; 273(1):209-18. PubMed ID: 23999542
[TBL] [Abstract][Full Text] [Related]
3. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
[TBL] [Abstract][Full Text] [Related]
4. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.
Lu H; Kaplan BL; Ngaotepprutaram T; Kaminski NE
J Leukoc Biol; 2009 Feb; 85(2):322-9. PubMed ID: 18988696
[TBL] [Abstract][Full Text] [Related]
5. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
Johnson-Léger C; Christensen J; Klaus GG
Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis.
Blair PJ; Riley JL; Harlan DM; Abe R; Tadaki DK; Hoffmann SC; White L; Francomano T; Perfetto SJ; Kirk AD; June CH
J Exp Med; 2000 Feb; 191(4):651-60. PubMed ID: 10684857
[TBL] [Abstract][Full Text] [Related]
7. CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection.
Newton CA; Chou PJ; Perkins I; Klein TW
J Neuroimmune Pharmacol; 2009 Mar; 4(1):92-102. PubMed ID: 18792785
[TBL] [Abstract][Full Text] [Related]
8. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
Jaiswal AI; Dubey C; Swain SL; Croft M
Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613
[TBL] [Abstract][Full Text] [Related]
10. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
Nakayama Y; Brinkman CC; Bromberg JS
Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
[TBL] [Abstract][Full Text] [Related]
11. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of expression and subset distribution of the TNF superfamily members CD40 ligand and Fas ligand on T lymphocytes in cattle.
Hirano A; Brown WC; Trigona W; Tuo W; Estes DM
Vet Immunol Immunopathol; 1998 Feb; 61(2-4):251-63. PubMed ID: 9613439
[TBL] [Abstract][Full Text] [Related]
13. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
14. Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events.
Karmaus PW; Chen W; Kaplan BL; Kaminski NE
J Neuroimmune Pharmacol; 2012 Dec; 7(4):843-55. PubMed ID: 21789506
[TBL] [Abstract][Full Text] [Related]
15. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
[TBL] [Abstract][Full Text] [Related]
16. Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation.
Ngaotepprutaram T; Kaplan BL; Carney S; Crawford R; Kaminski NE
Toxicology; 2013 Aug; 310():84-91. PubMed ID: 23727458
[TBL] [Abstract][Full Text] [Related]
17. B7/CD28-dependent and -independent induction of CD40 ligand expression.
Ding L; Green JM; Thompson CB; Shevach EM
J Immunol; 1995 Dec; 155(11):5124-32. PubMed ID: 7594521
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.
Koh WS; Crawford RB; Kaminski NE
Biochem Pharmacol; 1997 May; 53(10):1477-84. PubMed ID: 9260875
[TBL] [Abstract][Full Text] [Related]
19. Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection.
Wang Y; Gao D; Lunsford KE; Frankel WL; Bumgardner GL
Am J Transplant; 2003 Oct; 3(10):1251-8. PubMed ID: 14510698
[TBL] [Abstract][Full Text] [Related]
20. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]